Cyclosporins from Mycelium sterilae MS 2929

被引：4

作者：

Kuzma, Marek ^{[1
]}

Sedmera, Petr ^{[1
]}

Jegorov, Alexandr ^{[2
]}

Havlicek, Vladimir ^{[1
]}

机构：

[1] Acad Sci Czech Republ, Inst Microbiol, CR-14220 Prague, Czech Republic

[2] IVAX Pharmaceut, TAPI Galena, Res & Dev, Ceske Budejovice 37005, Czech Republic

来源：

JOURNAL OF NATURAL PRODUCTS | 2009年 / 72卷 / 01期

关键词：

IN-VITRO BIOSYNTHESIS; FAST-ATOM-BOMBARDMENT; A DERIVATIVES; SYNTHETASE; MECHANISMS; PEPTOLIDE; SHIFT;

D O I：

10.1021/np8003968

中图分类号：

Q94 [植物学];

学科分类号：

071001 ;

摘要：

The structures of two new cyclosporins were elucidated by NMR and MS methods as cyclo[-MeBmt(1)-Abu(2)-Sar(3)-MeLeu(4)-Val(5)-MeLeu(6)-Ala(7)-D-Ala(8)-MeLeu(9)-MeNva(10)-MeVal(11)-] and cyclo[-MeBmt(1)-Abu(2)-Sar(3)-MeLeu(4)-Abu(5)-MeLeu(6)-Ala(7)-D-Ala(8)-MeLeu(9)-MeLeu(10)-MeVal(11)-].

引用

页码：159 / 163

页数：5

共 36 条

[1] Substitution in position 3 of cyclosporin A abolishes the cyclophilin-mediated gain-of-function mechanism but not immunosuppression [J].

Baumgrass, R ;

Zhang, YX ;

Erdmann, F ;

Thiel, A ;

Weiwad, M ;

Radbruch, A ;

Fischer, G .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (04) :2470-2479

[2] ROLES OF PEPTIDYL-PROLYL CIS-TRANS ISOMERASE AND CALCINEURIN IN THE MECHANISMS OF ANTIMALARIAL ACTION OF CYCLOSPORINE-A, FK506, AND RAPAMYCIN [J].

BELL, A ;

WERNLI, B ;

FRANKLIN, RM .

BIOCHEMICAL PHARMACOLOGY, 1994, 48 (03) :495-503

[3] A cyclosporin from Mycelium sterilae [J].

Buchta, M ;

Jegorov, A ;

Cvak, L ;

Havlícek, V ;

Budesínsky, M ;

Sedmera, P .

PHYTOCHEMISTRY, 1998, 48 (07) :1195-1198

[4] Synthesis of non-immunosuppressive cyclophilin-binding cyclosporin a derivatives as potential anti-HIV-1 drugs [J].

Evers, M ;

Barrière, JC ;

Bashiardes, G ;

Bousseau, A ;

Carry, JC ;

Dereu, N ;

Filoche, B ;

Henin, Y ;

Sablé, S ;

Vuilhorgne, M ;

Mignani, S .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (24) :4415-4419

[5] CYCLOSPORINE - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC USE IN IMMUNOREGULATORY DISORDERS [J].

FAULDS, D ;

GOA, KL ;

BENFIELD, P .

DRUGS, 1993, 45 (06) :953-1040

[6] Topical cyclosporin in the treatment of dermatologic diseases [J].

Feliciani, C ;

Tulli, A .

INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2002, 15 (02) :89-93

[7] Pharmacological considerations in the modulation of multidrug resistance [J].

Fisher, GA ;

Lum, BL ;

Hausdorff, J ;

Sikic, BI .

EUROPEAN JOURNAL OF CANCER, 1996, 32A (06) :1082-1088

[8] Cyclosporin A prodrugs: design, synthesis and biophysical properties [J].

Hamel, AR ;

Hubler, F ;

Carrupt, A ;

Wenger, RM ;

Mutter, M .

JOURNAL OF PEPTIDE RESEARCH, 2004, 63 (02) :147-154

[9] SEQUENCING OF CYCLOSPORINS BY FAST-ATOM-BOMBARDMENT AND LINKED-SCAN MASS-SPECTROMETRY [J].

HAVLICEK, V ;

JEGOROV, A ;

SEDMERA, P ;

RYSKA, M .

ORGANIC MASS SPECTROMETRY, 1993, 28 (12) :1440-1447

[10] DISTINGUISHING ISOBARIC AMINO-ACIDS IN SEQUENCE-ANALYSIS OF CYCLOSPORINES BY FAST-ATOM-BOMBARDMENT AND LINKED-SCAN MASS-SPECTROMETRY [J].

HAVLICEK, V ;

JEGOROV, A ;

SEDMERA, P ;

WAGNERREDEKER, W ;

RYSKA, M .

JOURNAL OF MASS SPECTROMETRY, 1995, 30 (07) :940-948

← 1 2 3 4 →